Metropolitan Life Insurance Company (MetLife)’s Ingevity NGVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,934
| Closed | -$92.3K | – | 1371 |
|
|
2024
Q1 | $92.3K | Sell |
1,934
-221
| -10% | -$9.93K | ﹤0.01% | 1091 |
|
|
2023
Q4 | $102K | Hold |
2,155
| – | – | ﹤0.01% | 1068 |
|
|
2023
Q3 | $103K | Buy |
2,155
+96
| +5% | +$5.24K | 0.01% | 1000 |
|
|
2023
Q2 | $120K | Buy |
2,059
+62
| +3% | +$3.72K | 0.01% | 924 |
|
|
2023
Q1 | $143K | Sell |
1,997
-293
| -13% | -$23.3K | 0.01% | 814 |
|
|
2022
Q4 | $161K | Hold |
2,290
| – | – | 0.01% | 806 |
|
|
2022
Q3 | $139K | Hold |
2,290
| – | – | 0.01% | 833 |
|
|
2022
Q2 | $145K | Sell |
2,290
-179
| -7% | -$11.7K | 0.01% | 864 |
|
|
2022
Q1 | $158K | Sell |
2,469
-14,094
| -85% | -$943K | 0.01% | 935 |
|
|
2021
Q4 | $1.19M | Sell |
16,563
-184
| -1% | -$14K | 0.02% | 854 |
|
|
2021
Q3 | $1.2M | Sell |
16,747
-1,269
| -7% | -$100K | 0.02% | 828 |
|
|
2021
Q2 | $1.47M | Buy |
18,016
+381
| +2% | +$30.6K | 0.02% | 729 |
|
|
2021
Q1 | $1.33M | Sell |
17,635
-232
| -1% | -$16.9K | 0.02% | 760 |
|
|
2020
Q4 | $1.35M | Sell |
17,867
-983
| -5% | -$64K | 0.02% | 683 |
|
|
2020
Q3 | $932K | Sell |
18,850
-588
| -3% | -$33.2K | 0.02% | 788 |
|
|
2020
Q2 | $1.02M | Sell |
19,438
-4,053
| -17% | -$192K | 0.02% | 729 |
|
|
2020
Q1 | $827K | Sell |
23,491
-328
| -1% | -$19.2K | 0.02% | 777 |
|
|
2019
Q4 | $2.08M | Sell |
23,819
-171
| -0.7% | -$15K | 0.03% | 524 |
|
|
2019
Q3 | $2.04M | Sell |
23,990
-281
| -1% | -$25K | 0.03% | 496 |
|
|
2019
Q2 | $2.55M | Buy |
24,271
+62
| +0.3% | +$6.23K | 0.04% | 395 |
|
|
2019
Q1 | $2.56M | Buy |
24,209
+10,980
| +83% | +$1.1M | 0.05% | 357 |
|
|
2018
Q4 | $1.11M | Sell |
13,229
-413
| -3% | -$37.4K | 0.02% | 748 |
|
|
2018
Q3 | $1.39M | Hold |
13,642
| – | – | 0.02% | 736 |
|
|
2018
Q2 | $1.1M | Buy |
13,642
+681
| +5% | +$54.1K | 0.02% | 871 |
|
|
2018
Q1 | $955K | Sell |
12,961
-501
| -4% | -$37.5K | 0.01% | 924 |
|
|
2017
Q4 | $949K | Sell |
13,462
-15,139
| -53% | -$1.09M | 0.01% | 923 |
|
|
2017
Q3 | $1.79M | Sell |
28,601
-736
| -3% | -$43.6K | 0.01% | 974 |
|
|
2017
Q2 | $1.68M | Sell |
29,337
-664
| -2% | -$39.1K | 0.01% | 1006 |
|
|
2017
Q1 | $1.83M | Hold |
30,001
| – | – | 0.01% | 978 |
|
|
2016
Q4 | $1.65M | Sell |
30,001
-84
| -0.3% | -$4.03K | 0.01% | 1045 |
|
|
2016
Q3 | $1.39M | Sell |
30,085
-636
| -2% | -$26.9K | 0.01% | 1104 |
|
|
2016
Q2 | $1.05M | Buy |
+30,721
| New | +$959K | 0.01% | 1232 |
|
Other funds holding NGVT
ICP
SBH
Metropolitan Life Insurance Company (MetLife)'s NGVT Position: Q2 2024 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Ingevity (NGVT) in Q2 2024, closing a stake of 1,934 shares — an estimated $92.3K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in NGVT in Q2 2016 and held it in 32 quarters. The position peaked at $2.56M in Q1 2019. 266 funds tracked by Wall St. Rank hold NGVT as of Q2 2024.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Ingevity position as of Q2 2024 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 1,934 Ingevity shares in Q2 2024, an estimated $92.3K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Ingevity in Q2 2016 and held it in 32 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Ingevity position peaked at $2.56M in Q1 2019.
- 266 funds tracked by Wall St. Rank held Ingevity as of Q2 2024.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.